Downloads: 1
Case Study | Obstetrics and Gynecology | Volume 15 Issue 5, May 2026 | Pages: 449 - 453 | India
Conservative Management of Placental Hematomas with Dydrogesterone: A Case Series
Abstract: Placental hematomas are relatively common findings in early and mid-pregnancy and are managed predominantly with conservative, expectant strategies. However, evidence specific to placental hematomas remains limited. This case series describes our experience with four pregnancies complicated by placental hematomas and managed conservatively with dydrogesterone-based therapy. Case series: Four patients are presented. Their ages ranged from 22 to 28 years. They had retroplacental or intraplacental hematomas of varying sizes diagnosed during obstetric ultrasonography. All patients were treated with supportive therapy and dydrogesterone 30 mg per day. In all four patients the pregnancy was successfully carried to term, and they all delivered healthy babies. Taken together, the literature and our series support dydrogesterone as a preferred option associated with placental hematomas, while underscoring the need for larger, dedicated trials.
Keywords: Dydrogesterone, Placental hematoma, Placental abruption, Miscarriage, preterm birth
How to Cite?: Dr. Snehal Jagtap, Dr. Aniruddha Madan Jagtap, Dr. Sameer P Darawade, Dr. Rajashree Thoke, Dr. Dushyant Lal, "Conservative Management of Placental Hematomas with Dydrogesterone: A Case Series", Volume 15 Issue 5, May 2026, International Journal of Science and Research (IJSR), Pages: 449-453, https://www.ijsr.net/getabstract.php?paperid=SR26507144839, DOI: https://dx.dx.doi.org/10.21275/SR26507144839